Want to see AU:HIQ full AI Analyst Report?
Top Page
HitIQ Limited
(Sydney:HIQ)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.01
â–Ľ(-50.00% Downside)
Action:Reiterated
Date:08/29/26
The score is primarily constrained by very weak financial performance (sharp revenue contraction, extreme losses, ongoing cash burn, and negative equity). Valuation provides limited support due to a negative P/E and no dividend yield data, while technical positioning cannot be assessed because key indicators were not provided.
Positive Factors
Integrated Safety Technology Platform
The integrated hardware-and-software model can support differentiated data collection for teams, leagues, and athletes. A proprietary impact dataset and analytics workflow may strengthen product relevance and create opportunities for recurring institutional adoption.
Negative Factors
Severe Revenue Contraction
The sharp revenue decline signals weak commercial traction or an unstable sales base. Sustained contraction would reduce scale, limit investment capacity, and make it harder for the company to absorb fixed technology, personnel, and commercialization costs.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated Safety Technology Platform
The integrated hardware-and-software model can support differentiated data collection for teams, leagues, and athletes. A proprietary impact dataset and analytics workflow may strengthen product relevance and create opportunities for recurring institutional adoption.
Read all positive factors
HitIQ Limited (HIQ) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$5.79M
Dividend YieldN/A
Average Volume (3M)618.21K
Price to Earnings (P/E)―
Beta (1Y)0.30
Revenue Growth-45.59%
EPS Growth38.29%
CountryAU
Employees25
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,158,683,500
10 Day Avg. Volume1,040,803
30 Day Avg. Volume618,206
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-0.63
Price to Sales (P/S)10.84
P/FCF Ratio-1.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HitIQ Limited Business Overview & Revenue Model
Company Description
HITIQ Limited is an Australian enterprise focused on developing and commercializing advanced technology for concussion management. Its Nexus software platform delivers comprehensive data and analytical insights concerning head impacts, empowering ...
How the Company Makes Money
null...
HitIQ Limited Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
10
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 366.33K | 2.01M | 4.75M | 774.26K | 619.02K |
| Gross Profit | 290.78K | -2.18M | 334.63K | 242.73K | 243.43K |
| EBITDA | -6.37M | -5.99M | -2.54M | -4.31M | -6.54M |
| Net Income | -6.10M | -7.21M | -3.20M | -5.04M | -6.95M |
Balance Sheet | |||||
| Total Assets | 1.72M | 3.28M | 3.73M | 3.13M | 4.55M |
| Cash, Cash Equivalents and Short-Term Investments | 173.64K | 990.96K | 584.02K | 1.98M | 2.94M |
| Total Debt | 2.27M | 5.66M | 3.20M | 1.69M | 2.16M |
| Total Liabilities | 8.04M | 7.30M | 5.20M | 3.18M | 3.38M |
| Stockholders Equity | -6.32M | -4.02M | -1.47M | -46.86K | 1.17M |
Cash Flow | |||||
| Free Cash Flow | -3.69M | -4.68M | -4.12M | -4.57M | -6.57M |
| Operating Cash Flow | -3.66M | -4.65M | -4.10M | -4.51M | -6.51M |
| Investing Cash Flow | -31.02K | -28.57K | -20.78K | -54.73K | -918.06K |
| Financing Cash Flow | 2.87M | 5.09M | 2.73M | 3.61M | 1.41M |
HitIQ Limited Technical Analysis
Negative
0.02
Price Trends
0.01
Negative
0.01
Negative
0.02
Negative
Market Momentum
>-0.01
Negative
40.79
Neutral
40.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:HIQ, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of <0.01, above the 50-day MA of 0.01, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 40.79 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:HIQ.
HitIQ Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | AU$515.97M | 30.90 | 21.61% | 1.99% | 6.95% | 10.77% | |
61 Neutral | AU$141.73M | 58.82 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | AU$31.01M | -1.67 | -58.13% | ― | 2.08% | -195.31% | |
47 Neutral | AU$24.04M | -2.65 | -1688.04% | ― | 11.45% | 0.69% | |
43 Neutral | AU$43.25M | -3.73 | -18.10% | ― | ― | ― | |
42 Neutral | AU$5.79M | -0.37 | 106.16% | ― | -45.59% | 38.29% |
* Healthcare Sector Average
AU:HIQ
HitIQ Limited
0.01
-0.01
-50.00%
AU:CGS
Cogstate Ltd
3.01
1.12
59.68%
AU:PKY
Opyl Ltd.
0.03
<0.01
15.38%
AU:BMT
Beamtree Holdings Ltd
0.11
-0.12
-52.27%
AU:ALC
Alcidion Group Limited
0.10
0.01
11.11%
AU:PCK
PainChek Ltd
0.12
-0.40
-77.45%
HitIQ Limited Corporate Events
HITIQ Issues 198 Million New Shares Under Corporations Act Notice
Aug 28, 2026
HITIQ Limited has issued 198,412,698 fully paid ordinary shares on 26 August 2026 without a disclosure document under the relevant capital-raising provisions of the Corporations Act. The company states it remains compliant with its continuous disc...
HitIQ Outlines Proportional Governance Approach in ASX Compliance Statement
Aug 28, 2026
HitIQ Limited has released its latest corporate governance statement, detailing how it applies the ASX Corporate Governance Council’s fourth edition principles as at 27 August 2026. The board concludes that, given the company’s current...
HitIQ Files Updated Corporate Governance Statement with ASX
Aug 28, 2026
HitIQ Limited has lodged its latest corporate governance statement for the year ended 30 June 2026 with the ASX, providing investors with web-based access to its governance disclosures under the ASX Corporate Governance Council framework. The stat...
HitIQ Narrows Annual Loss Despite Revenue Fall and Maintains No-Dividend Stance
Aug 28, 2026
HitIQ Limited reported a 21% decline in revenue from ordinary activities to $1.59 million for the year ended 30 June 2026, while narrowing its after‑tax loss to $6.1 million from $7.2 million a year earlier. The company again did not declare...
HitIQ Expands Share Base After Partial Convertible Note Conversion
Aug 26, 2026
HitIQ Limited has applied to the ASX for quotation of 198,412,698 new ordinary fully paid shares, issued on 26 August 2026 following a partial conversion of an existing convertible note. The move increases the company’s quoted share base, si...
HitIQ Issues 3 Million Unquoted Performance Rights
Aug 24, 2026
HitIQ Limited has notified the market of the issue of 3,000,000 unquoted performance rights, recorded under ASX security code HIQAU, effective 24 August 2026. The new securities form part of previously announced transactions and are not intended t...
HitIQ Plans Issue of 3 Million Performance Rights on ASX
Aug 20, 2026
HitIQ Limited has notified the ASX of a proposed issue of up to 3,000,000 performance rights, to be classified under the ASX security code HIQAU. The securities are to be issued as part of a placement or other type of issue, with a proposed issue ...
HitIQ advances defence strategy with U.S. military research tie-up and strategic advisor
Aug 20, 2026
HitIQ Limited has entered a non-binding Letter of Intent with the University of Southern Mississippi’s Sport and Tactical Athlete Research Lab and the University of Mississippi’s National Center for Tactical Readiness. The collaboratio...
HitIQ director boosts direct shareholding through performance rights conversion
Aug 13, 2026
HitIQ Limited has reported a change in the interests of director Matthew Clayworth, detailing movements across his direct holdings and those held via related investment and superannuation vehicles. The disclosure highlights his roles and beneficia...
HitIQ Calls September General Meeting as Concussion Tech Platform Advances
Aug 6, 2026
HitIQ Limited has called a General Meeting of shareholders to be held at its South Melbourne offices on 7 September 2026, with the record date for voting set at 7:00pm AEST on 5 September 2026. The company has circulated a formal notice of meeting...
HitIQ Issues New Shares and Affirms Ongoing Regulatory Compliance
Aug 6, 2026
HitIQ Limited has notified investors that it has issued 1,704,546 fully paid ordinary shares, confirming that these were issued without a disclosure document under the relevant fundraising provisions of the Corporations Act. The company states it ...
HitIQ Seeks ASX Quotation for 1.7 Million New Shares
Aug 6, 2026
HitIQ Limited has applied for the quotation of 1,704,546 new ordinary fully paid shares on the ASX, with an issue date of 5 August 2026. The additional securities, arising from the exercise or conversion of existing options or other convertible in...
HitIQ bolsters funding and manufacturing as brain health platform expands
Jul 29, 2026
HitIQ Limited reported a June 2026 quarter marked by a strengthened balance sheet and enhanced financial flexibility, securing firm commitments for about $1.4 million in new equity and fully drawing down a $1.0 million working capital facility. Th...
HitIQ details final shareholdings of departing director Jennifer Tucker
Jul 27, 2026
HitIQ Limited has notified the ASX of the final interests held by director Jennifer Tucker following her cessation from the board on 24 July 2026. The filing details her holdings of 1,034,173 fully paid ordinary shares, 79,587 listed options and 4...
HitIQ Director Resignation Highlights Governance Shift Amid Concussion Tech Focus
Jul 27, 2026
HitIQ Limited has announced the resignation of non-executive director Jennifer Tucker, who is stepping down to focus on other business and professional endeavours after serving on the board since January 2025. Chair Earl Eddings thanked Tucker for...
HitIQ Links ASX Price Query to Recent $1.4m Placement
Jul 10, 2026
HitIQ Limited has responded to an ASX price query, stating it is not aware of any undisclosed information that would explain recent trading activity in its securities. The company emphasised that it remains in compliance with ASX Listing Rules, in...
HitIQ Confirms Regulatory Compliance on New Share Issue
Jul 6, 2026
HitIQ Limited has issued 95,714,290 fully paid ordinary shares and has notified the market that this capital raising was conducted without a prospectus or disclosure document under the provisions of the Corporations Act. The company affirms it is ...
HITIQ Issues Over 82 Million New Shares and Confirms Regulatory Compliance
Jul 3, 2026
HITIQ Limited has issued 82,618,373 fully paid ordinary shares and notified the market that this issuance was conducted without a disclosure document under the relevant provisions of the Corporations Act. The company confirmed it remains compliant...
HitIQ Seeks ASX Quotation for New Service-Linked Share Issue
Jul 3, 2026
HitIQ Limited has applied for quotation on the ASX of 2,346,939 ordinary fully paid shares issued as partial consideration for services provided to the company. The new securities, dated 3 July 2026, reflect HitIQ’s use of equity to compensa...
HitIQ seeks ASX quotation for over 80 million new shares
Jul 3, 2026
HitIQ Limited has applied for quotation on the ASX of 80,271,434 new ordinary fully paid shares, to be issued on July 3, 2026. The application underlines the company’s ongoing capital management and market activities, potentially expanding i...
HitIQ plans major capital raise with new shares and options issue
Jun 29, 2026
HitIQ Limited has outlined plans for a significant capital raise through the proposed issue of 200 million new fully paid ordinary shares on the ASX. The company will also issue two new classes of options, each with a $0.007 exercise price and exp...
HITIQ Raises A$1.4m to Fund Expansion of Concussion Technology
Jun 29, 2026
HITIQ Limited has secured firm commitments from professional and sophisticated investors to raise A$1.4 million via a two-tranche placement of 200 million new shares at A$0.007 each, with investors receiving free unlisted options that may convert ...
HitIQ Seeks Trading Halt Ahead of Material Capital Raising
Jun 24, 2026
HitIQ Limited has requested an immediate trading halt on its securities on the ASX, as the company prepares to announce a material capital raising. The halt, granted under ASX Listing Rules, is intended to help HitIQ manage its continuous disclosu...
HitIQ Options Class HIQOA Reinstated to ASX Quotation
Jun 17, 2026
HitIQ Limited’s HIQOA class of quoted options will be reinstated to trading on the ASX following an announcement relating to Federal Court of Australia orders affecting this security class. The decision by ASX Compliance to allow immediate r...
HITIQ Wins Court Approval to Extend ASX Quotation Deadline for Listed Options
Jun 17, 2026
HITIQ Limited has secured Federal Court orders extending the period for ASX admission to quotation of its HIQOA listed options, which were issued under a May 2025 prospectus. The decision resolves a compliance issue under the Corporations Act, all...
HitIQ Director Earl Eddings Increases Shareholding via On‑Market Purchase
Jun 10, 2026
HitIQ Limited has disclosed a change in director Earl Eddings’ relevant interests, reporting that he increased his direct holding in the company through an on‑market share purchase. Eddings acquired 478,591 fully paid ordinary shares a...
HitIQ Seeks Extension of Trading Suspension on HIQOA Options Amid Court Bid
Jun 3, 2026
HitIQ Limited has requested an immediate extension to the voluntary suspension of its HIQOA listed options on the ASX, as it continues court proceedings related to the timing of their admission to quotation. The options were issued under a 15 May ...
HitIQ Says No Undisclosed Information Behind Share Price Move
Jun 3, 2026
HitIQ Limited has responded to an ASX price query, stating it is not aware of any undisclosed information that could explain the recent increase in trading of its securities. The company emphasised that it has no inside information affecting its s...
HITIQ Completes Drawdown of $1m Shareholder-Backed Loan for Working Capital
Jun 2, 2026
HITIQ Limited has fully drawn down the remaining A$350,000 of a previously announced A$1 million loan facility from No Bull Health, an associate of major shareholder Harmil Angel Investments, bringing total advances to A$1 million. The additional ...
HitIQ Director Earl Eddings Lifts Indirect Stake via Family Super Fund
Jun 1, 2026
HitIQ director Earl Eddings has increased his indirect shareholding in the company through his family superannuation fund, E4 Super Pty Ltd ATF E4 Family Super Fund. The fund acquired 100,000 fully paid ordinary shares on market at $0.01 per share...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.